NR4A2 is involved in autoimmune and neurodegenerative diseases, especially in Parkinson’s disease, where the reduced expression of this gene in peripheral blood can be considered as a potential biomarker for diagnosis, and a promising approach to therapy [59,60,61,62]. Here, NR4A2 is linked to neurodegenerative disease.